Browse Category

NYSE:TDG 12 November 2025 - 4 February 2026

TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm (TDG) stock falls again as Baird downgrade keeps pressure on share price

TransDigm shares fell 2.3% to $1,271.89 Wednesday after Baird downgraded the stock and cut its price target to $1,400. The company reported a 14% rise in net sales to $2.285 billion for the fiscal first quarter, but net income dropped nearly 10% to $445 million due to higher interest expenses. TransDigm raised its 2026 profit forecast but kept the midpoint below analyst expectations.
4 February 2026
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 17.01.2026

TransDigm Group reported $8.83 billion in revenue and $1.87 billion net income, with shares near $1,450 and a P/E of 43.8x. Elevance Health closed at $374.87, with DCF analysis suggesting a 62.9% undervaluation. BlackRock traded at $1,163.17, about 11.6% above its implied value. Commercial Metals ended at $74.42, with DCF pointing to a 37.3% discount to intrinsic value.
17 January 2026
Nasdaq Stumbles as Fed Jitters Mount, Intel Soars, Tariffs Rattle Tech Markets

US Stock Market Today, Nov. 12, 2025: Futures Climb as House Vote Aims to End Shutdown; CPI on Deck—What to Watch Before the Opening Bell

U.S. stock futures rose Wednesday as investors anticipated a House vote to end the 42-day federal shutdown, following Senate approval of a funding bill. The 10-year Treasury yield hovered near 4.09%. Oil and gold were steady. AMD jumped pre-market on strong AI guidance, while Nvidia sentiment was mixed after SoftBank’s stake sale.
Go toTop